Copyright
©The Author(s) 2021.
World J Crit Care Med. May 9, 2021; 10(3): 47-57
Published online May 9, 2021. doi: 10.5492/wjccm.v10.i3.47
Published online May 9, 2021. doi: 10.5492/wjccm.v10.i3.47
COVID-19+, n = 274 (56.5%) | COVID-19−, n = 211 (43.5%) | Total, n = 485 | P value | ||
Age (yr) | 50.9 ± 10.9 | 40.4 ± 12.3 | 46.4 ± 12.7 | < 0.001c | |
Male gender, n (%) | 144 (52.6) | 113 (53.6) | 257 (53.0) | 0.450 | |
Hepatic steatosis, n (%) | Presence | 112 (40.9) | 41 (19.4) | 153 (31.5) | < 0.001c |
Absence | 162 (58.1) | 170 (80.6) | 332 (68.5) | ||
Liver's attenuation (HU) | 45.7 ± 11.4 | 53.9 ± 15.9 | 49.3 ± 14.2 | < 0.001c | |
Comorbidities | |||||
Obesity (BMI ≥ 30 kg/m2) | 45 (16.4) | 13 (6.2) | 58 (12.0) | 0.001b | |
Overweight (BMI 25–29.9 kg/m2) | 153 (55.8) | 55 (26.1) | 208 (42.9) | < 0.001c | |
Diabetes mellitus | 68 (24.8) | 29 (13.7) | 97 (20.0) | 0.003b | |
Hypertension | 107 (39.1) | 37 (17.5) | 144 (29.7) | < 0.001c | |
Cardiac disease | 36 (13.1) | 23 (10.9) | 59 (12.2) | 0.455 | |
Chronic lung disease | 29 (10.6) | 24 (13.7) | 53 (10.9) | 0.896 | |
No comorbidity1 | 136 (49.6) | 129 (61.1) | 265 (54.6) | 0.012a | |
Smoking history | 57 (20.8) | 56 (26.1) | 112 (23.1) | 0.110 | |
Alcohol usage | 4 (1.5) | 4 (1.9) | 8 (1.6) | 0.709 |
Variable | Steatosis+, n = 112 | Steatosis−, n = 162 | Total, n = 284 | P value |
Age (yr) | 51.2 ± 9.2 | 50.7 ± 10.1 | 50.9 ± 10.9 | 0.321 |
Male gender, n (%) | 65 (58.0) | 79 (48.8) | 144 (52.6) | 0.131 |
Liver's attenuation, Hounsfield unit | 34.2 ± 4.8 | 53.6 ± 7.2 | 45.7 ± 11.5 | < 0.001c |
Pneumonia severity score | 8.6 ± 3.5 | 6.8 ± 3.2 | 7.5 ± 3.4 | < 0.001c |
Comorbidities | ||||
Obesity (BMI ≥ 30 kg/m2) | 28 (25.0) | 17 (10.5) | 45 (16.4) | 0.001b |
Overweight (BMI 25-29.9 kg/m2) | 69 (61.6) | 65 (40.6) | 134 (48.9) | < 0.001c |
Diabetes mellitus | 33 (29.5) | 35 (21.6) | 68 (24.8) | 0.139 |
Hypertension | 42 (37.5) | 65 (40.1) | 107 (39.1) | 0.662 |
Cardiac disease | 13 (11.6) | 23 (14.2) | 36 (13.1) | 0.533 |
Chronic lung disease | 12 (10.7) | 18 (11.1) | 30 (10.9) | 0.918 |
No comorbidity1 | 54 (48.2) | 82 (50.6) | 136 (49.6) | 0.696 |
Smoking history | 18 (16.1) | 39 (24.1) | 57 (20.8) | 0.109 |
Alcohol usage | 4 (3.6) | 0 (0) | 4 (1.5) | 0.015a |
- Citation: Tahtabasi M, Hosbul T, Karaman E, Akin Y, Kilicaslan N, Gezer M, Sahiner F. Frequency of hepatic steatosis and its association with the pneumonia severity score on chest computed tomography in adult COVID-19 patients. World J Crit Care Med 2021; 10(3): 47-57
- URL: https://www.wjgnet.com/2220-3141/full/v10/i3/47.htm
- DOI: https://dx.doi.org/10.5492/wjccm.v10.i3.47